| scholarly article | Q13442814 |
| P2093 | author name string | S M Schwartz | |
| S D Hauschka | |||
| R W Wiseman | |||
| C E Murry | |||
| P2860 | cites work | The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage | Q24310740 |
| Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts | Q24629391 | ||
| Differentiation and long-term survival of C2C12 myoblast grafts in heart | Q33903190 | ||
| Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis | Q34193341 | ||
| Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation | Q34355279 | ||
| Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs | Q35765110 | ||
| Lethal myocardial ischemic injury | Q35863602 | ||
| Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro | Q36209334 | ||
| Heterokaryon analysis of muscle differentiation: regulation of the postmitotic state | Q36217406 | ||
| Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi. | Q37153248 | ||
| Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. | Q37361343 | ||
| Cardiac myocyte terminal differentiation. Potential for cardiac regeneration | Q40528547 | ||
| N-cadherin and N-CAM-mediated adhesion in development and regeneration of skeletal muscle | Q40754286 | ||
| Tumor suppressor gene expression during normal and pathologic myocardial growth | Q41442758 | ||
| Expression of gap junctions in cultured rat L6 cells during myogenesis | Q41576757 | ||
| The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow | Q41640497 | ||
| Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation | Q41673982 | ||
| Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells | Q41738333 | ||
| Contractile cells in rat myocardial scar tissue | Q42472025 | ||
| Fate of nerve fibers in necrotic, healing, and healed rat myocardium | Q42482120 | ||
| Myocyte reactions at the borders of injured and healing rat myocardium | Q42519186 | ||
| Three slow myosin heavy chains sequentially expressed in developing mammalian skeletal muscle. | Q42804847 | ||
| Clonal analysis of vertebrate myogenesis. II. Environmental influences upon human muscle differentiation | Q47873247 | ||
| Developmental progression of myosin gene expression in cultured muscle cells. | Q52260289 | ||
| Histochemical and fatigue characteristics of conditioned canine latissimus dorsi muscle. | Q54432952 | ||
| Alpha 1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery | Q67488041 | ||
| N-cadherin and N-CAM in myoblast fusion: compared localisation and effect of blockade by peptides and antibodies | Q67993537 | ||
| Muscle fiber typing in routinely processed skeletal muscle with monoclonal antibodies | Q68416537 | ||
| Effect of intracellular pH on force development depends on temperature in intact skeletal muscle from mouse | Q71620112 | ||
| Impairment of myocyte contractility following coronary artery narrowing is associated with activation of the myocyte IGF1 autocrine system, enhanced expression of late growth related genes, DNA synthesis, and myocyte nuclear mitotic division in rats | Q72227766 | ||
| Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium | Q72321699 | ||
| End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes | Q72791594 | ||
| The effect of metabolic fuel on force production and resting inorganic phosphate levels in mouse skeletal muscle | Q72831872 | ||
| Myocardial regeneration with satellite cell implantation | Q72901283 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myoblast | Q1956694 |
| P304 | page(s) | 2512-2523 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Skeletal myoblast transplantation for repair of myocardial necrosis | |
| P478 | volume | 98 |
| Q89860241 | ARH1 in Health and Disease |
| Q34477403 | Adhesion proteins, stem cells, and arrhythmogenesis |
| Q35842254 | Adult-derived stem cells from the liver become myocytes in the heart in vivo |
| Q38843350 | Advances in stem cell therapy for cardiovascular disease (Review). |
| Q89142435 | Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes |
| Q46267096 | An in vitro beating heart model for long-term assessment of experimental therapeutics. |
| Q30480151 | Angiomyogenesis for myocardial repair |
| Q44392643 | Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction |
| Q73105476 | Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation |
| Q50488914 | Autologous stem cell transplantation for myocardial repair. |
| Q36163310 | Basic progress and future therapeutic perspectives of relaxin in ischemic heart disease |
| Q35022763 | Beyond collagen: injectable therapies for the treatment of female stress urinary incontinence in the new millennium |
| Q55320223 | Beyond the Mammalian Heart: Fish and Amphibians as a Model for Cardiac Repair and Regeneration. |
| Q55066749 | Biomaterial property-controlled stem cell fates for cardiac regeneration. |
| Q35676018 | Bone marrow and bone marrow derived mononuclear stem cells therapy for the chronically ischemic myocardium |
| Q39615478 | Bone marrow stromal cells contract synchronously with cardiomyocytes in a coculture system |
| Q37422757 | Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium |
| Q58108890 | Building the translational highway: toward new partnerships between academia and the private sector |
| Q57951477 | COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients After Acute Myocardial Infarction and Left Ventricular Dysfunction: Study Rationale and Design |
| Q36146340 | Cardiac Regeneration and Stem Cells. |
| Q24615347 | Cardiac applications for human pluripotent stem cells |
| Q30477766 | Cardiac conduction through engineered tissue |
| Q34617472 | Cardiac regeneration using pluripotent stem cells--progression to large animal models. |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q36349185 | Cardiac repair by embryonic stem-derived cells |
| Q36579504 | Cardiac repair--fact or fancy? |
| Q36267790 | Cardiac stem cells and mechanisms of myocardial regeneration |
| Q34377754 | Cardiac tissue development for delivery of embryonic stem cell-derived endothelial and cardiac cells in natural matrices |
| Q57071128 | Cardiac tissue engineering: current state-of-the-art materials, cells and tissue formation |
| Q38172390 | Cardiac tissue engineering: renewing the arsenal for the battle against heart disease |
| Q31148531 | Cardiomyocyte regeneration from circulating bone marrow cells in mice |
| Q35184026 | Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure? |
| Q33843659 | Cardiomyocytes can be generated from marrow stromal cells in vitro |
| Q38039022 | Cardiovascular surgery for realization of regenerative medicine |
| Q57159453 | Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future |
| Q77802850 | Cell cycle control in the terminally differentiated myocyte. A platform for myocardial repair? |
| Q33828642 | Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q33295408 | Cell therapy in congestive heart failure |
| Q34933415 | Cell therapy of heart failure |
| Q37388609 | Cell therapy with bone marrow cells for myocardial regeneration |
| Q35547250 | Cell transplantation and genetic engineering: new approaches to cardiac pathology |
| Q37118515 | Cell transplantation for cardiac regeneration: where do we stand? |
| Q35160112 | Cell transplantation in myocardium |
| Q44687812 | Cell transplantation to prevent heart failure: a comparison of cell types. |
| Q36883759 | Cell-based cardiac pumps and tissue-engineered ventricles |
| Q35874249 | Cell-based myocardial repair: how should we proceed? |
| Q36669952 | Cellular cardiomyoplasty by catheter-based infusion of stem cells in clinical settings |
| Q24806964 | Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure |
| Q35049294 | Cellular cardiomyoplasty: cell therapy for myocardial regeneration |
| Q37731741 | Challenges in the translation of cardiovascular cell therapy |
| Q38086843 | Choice of cell-delivery route for successful cell transplantation therapy for the heart |
| Q49029956 | Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy |
| Q37318863 | Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. |
| Q47970458 | Comparison of intra-coronary cell transplantation after myocardial infarction: Autologous skeletal myoblasts versus bone marrow mesenchymal stem cells |
| Q36406455 | Contemplating the bright future of stem cell therapy for cardiovascular disease |
| Q38297845 | Control of myoblast proliferation with a synthetic ligand |
| Q58861286 | Could the coculture of skeletal myoblasts and mesenchymal stem cells be a solution for postinfarction myocardial scar? |
| Q39818744 | Current and Future Status of Stem Cell Therapy in Heart Failure |
| Q34186427 | Current and future NIH support of biomedical research. |
| Q35949692 | Current clinical perspectives on myocardial angiogenesis. |
| Q38058287 | Current status of myocardial regeneration therapy |
| Q35184029 | Diabetic heart dysfunction: is cell transplantation a potential therapy? |
| Q81123128 | Differential myocardial infarct repair with muscle stem cells compared to myoblasts |
| Q36016039 | Dynamic Support Culture of Murine Skeletal Muscle-Derived Stem Cells Improves Their Cardiogenic Potential In Vitro |
| Q44173960 | Effect of cryoinjury on the contractile parameters of bladder strips: a model of impaired detrusor contractility |
| Q39145446 | Effects of cell grafting on coronary remodeling after myocardial infarction. |
| Q36327602 | Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair |
| Q40479961 | Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. |
| Q33680680 | Engineering of aligned skeletal muscle by micropatterning. |
| Q51579664 | Engineering skeletal myoblasts: roles of three-dimensional culture and electrical stimulation. |
| Q51812371 | Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. |
| Q30623801 | Enhanced gap junction expression in myoblast-containing engineered tissue |
| Q48692636 | Exogenous connexin43-expressing autologous skeletal myoblasts ameliorate mechanical function and electrical activity of the rabbit heart after experimental infarction |
| Q37302427 | Fabrication of skeletal muscle constructs by topographic activation of cell alignment. |
| Q38129288 | Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity |
| Q37374412 | Focal gap junction uncoupling and spontaneous ventricular ectopy. |
| Q35221817 | Formation of human myocardium in the rat heart from human embryonic stem cells |
| Q36569726 | From cardiac repair to cardiac regeneration--ready to translate? |
| Q26865425 | Gene and cell therapies for the failing heart to prevent sudden arrhythmic death |
| Q36675432 | Gene and cell therapy for chronic ischaemic heart disease |
| Q36853977 | Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function |
| Q34311785 | Genetic modification of xenografts |
| Q37766154 | Getting to the heart of tissue engineering. |
| Q33605156 | Heart failure management: the present and the future |
| Q37023827 | Human embryonic stem cells and cardiac repair |
| Q35184036 | Human embryonic stem cells for myocardial regeneration |
| Q58371229 | Improved regional left ventricular function after successful satellite cell grafting in rabbits with myocardial infarction |
| Q34358919 | Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium |
| Q37294345 | Injectable cardiac tissue engineering for the treatment of myocardial infarction |
| Q61776510 | Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ |
| Q48922938 | Labeling of skeletal myoblasts with a novel oxygen-sensing spin probe for noninvasive monitoring of in situ oxygenation and cell therapy in heart. |
| Q47589036 | Long-term results of autologous stem cell transplantation in the treatment of patients with congestive heart failure. |
| Q37506545 | Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? |
| Q43251593 | Making stem cells infarct avid |
| Q74341231 | Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects |
| Q33765470 | Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration |
| Q37000697 | Mesenchymal stem cells for vascular regeneration |
| Q73791469 | Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts |
| Q44592644 | Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation |
| Q37859370 | Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions |
| Q37296154 | Metabolic modulation and cellular therapy of cardiac dysfunction and failure |
| Q36477618 | Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease |
| Q31002195 | Mobilized bone marrow cells repair the infarcted heart, improving function and survival |
| Q37314112 | Modulation of Human Cardiac Progenitors via Hypoxia-ERK Circuit Improves their Functional Bioactivities. |
| Q36416525 | Molecular imaging of cardiac stem cell transplantation |
| Q35856369 | Molecular imaging of cardiovascular gene products |
| Q34803109 | Molecular medicine for the cardiac surgeon |
| Q64379940 | Muscle-derived cell transplantation and differentiation into lower urinary tract smooth muscle |
| Q36424273 | Muscling in on stem cells. |
| Q37157338 | MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases |
| Q35724599 | Myoblast transfer in heart failure |
| Q58109127 | Myoblast transplantation for heart failure |
| Q35184032 | Myoblast-based cell transplantation |
| Q35146911 | Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host |
| Q26999246 | Myocardial cell sheet therapy and cardiac function |
| Q33786676 | Myocardial protection: is there a role for gene therapy? |
| Q31979394 | Myocardial tissue engineering with autologous myoblast implantation |
| Q34503420 | Myocyte renewal and ventricular remodelling |
| Q37092188 | Myocyte replacement therapy: skeletal myoblasts |
| Q34268325 | Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart |
| Q40785082 | Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium |
| Q36622723 | Neoplastic stem cells: a novel therapeutic target in clinical oncology |
| Q35949674 | Neovascularization derived from cell transplantation in ischemic myocardium. |
| Q35108283 | New directions in strategies using cell therapy for heart disease |
| Q39602637 | Non-invasive bioluminescence imaging of myoblast-mediated hypoxia-inducible factor-1 alpha gene transfer |
| Q40300829 | Noninvasive evaluation of immunosuppressive drug efficacy on acute donor cell survival |
| Q47350563 | On the fate of skeletal myoblasts in a cardiac environment: down-regulation of voltage-gated ion channels |
| Q37606311 | Organotypic heart slices for cell transplantation and physiological studies. |
| Q39817615 | Oscillating pressure treatment upregulates connexin43 expression in skeletal myoblasts and enhances therapeutic efficacy for myocardial infarction |
| Q36571199 | Overview of stem cells and imaging modalities for cardiovascular diseases |
| Q33875374 | Pluripotent stem cell derived cardiomyocytes for cardiac repair |
| Q39638034 | Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization |
| Q33653191 | Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation |
| Q36108608 | Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope? |
| Q36804591 | Realizing the cardiac stem cell promise: a case for trophism |
| Q38096037 | Recent advancements in tissue engineering for stem cell-based cardiac therapies |
| Q45882958 | Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells |
| Q33375103 | Regulation of hypoxic response elements on the expression of vascular endothelial growth factor gene transfected to rat skeletal myoblasts under hypoxic environment |
| Q46037653 | Regulation of myocardial extracellular matrix components by mechanical and chemical growth factors. |
| Q37104058 | Repairing damaged myocardium: evaluating cells used for cardiac regeneration |
| Q35184059 | Reprogramming cells for transplantation. |
| Q37766134 | Review of stem cell-based therapy for the treatment of cardiovascular disease |
| Q64942829 | Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair. |
| Q37964251 | Role of molecular imaging in stem cell therapy for myocardial restoration |
| Q33809635 | Role of stem cells in cardiovascular biology |
| Q51820418 | Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium. |
| Q73223494 | Skeletal muscle meets cardiac muscle. Friends or foes? |
| Q37810057 | Skeletal myoblasts for cardiac repair |
| Q53537606 | Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. |
| Q35945147 | Some notes on stem cell therapy in cardiovascular diseases |
| Q37511101 | Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation |
| Q38804863 | State-of-the-Art Review of 3D Bioprinting for Cardiovascular Tissue Engineering |
| Q28069300 | Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet? |
| Q50075212 | Stem Cells in Regenerative Cardiology |
| Q34981433 | Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges |
| Q37045472 | Stem cell differentiation: cardiac repair |
| Q37544884 | Stem cell therapy for cardiac repair: benefits and barriers |
| Q30478781 | Stem cell therapy for myocardial repair |
| Q26865849 | Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications |
| Q34315088 | Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation |
| Q37766151 | Stem cells and cardiac repair: a critical analysis |
| Q57635832 | Stem cells and cardiovascular tissue repair: Mechanism, methods, and clinical applications |
| Q35832759 | Stem cells and repair of the heart. |
| Q38719172 | Surface geometry of poly(ether imide) boosts mouse pluripotent stem cell spontaneous cardiomyogenesis via modulating the embryoid body formation process |
| Q37946665 | Synthetic matrices to serve as niches for muscle cell transplantation |
| Q36984663 | Systems approaches to preventing transplanted cell death in cardiac repair. |
| Q35164884 | Targeting the cell cycle machinery for the treatment of cardiovascular disease. |
| Q36174197 | The bone marrow--cardiac axis of myocardial regeneration |
| Q38274270 | The role of tissue engineering and biomaterials in cardiac regenerative medicine |
| Q33793856 | The study of the intercellular trafficking of the fusion proteins of herpes simplex virus protein VP22 |
| Q34635645 | The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine |
| Q35777375 | Therapeutic angiogenesis for myocardial ischemia |
| Q36355287 | Tissue engineering: construction of a multicellular 3D scaffold for the delivery of layered cell sheets |
| Q96304765 | Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies |
| Q40334464 | Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation |
| Q52729630 | Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. |
| Q40833666 | Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? |
| Q51549947 | Transplantation of Marrow-Derived Cardiac Stem Cells Carried in Fibrin Improves Cardiac Function After Myocardial Infarction |
| Q35082284 | Transplantation of cells for cardiac repair |
| Q38775197 | Transplantation of human villous trophoblasts preserves cardiac function in mice with acute myocardial infarction |
| Q37356852 | Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium |
| Q53486196 | Uterine cells-an immunoprivileged cell source for therapy-but are they for everyone? |
| Q34572172 | Xenotransplantation and other means of organ replacement |
Search more.